The Cumulative Risk Assessment of Hepatotoxic Chemicals: A Hepatic Histopathology Perspective

Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium

(2018) Mario Strazzabosco et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Predicting drug-induced cholestasis: preclinical models

(2018) Petar D. Petrov et al.   Expert Opinion on Drug Metabolism & Toxicology

Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators

(2018) Brian G. Lake   Toxicology Research

The association between chemical-induced porphyria and hepatic cancer

(2018) Andrew G. Smith et al.   Toxicology Research

Mitochondrial dysfunction-related lipid changes occur in non-alcoholic fatty liver disease progression

(2018) Kang-Yu Peng et al.   JOURNAL OF LIPID RESEARCH

Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury

(2017) Richard J. Weaver et al.   Expert Opinion on Drug Metabolism & Toxicology

Regulatory assessment of chemical mixtures: Requirements, current approaches and future perspectives

(2016) Aude Kienzler et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Recommendations from the INHAND Apoptosis/Necrosis Working Group

(2016) Susan A. Elmore et al.   TOXICOLOGIC PATHOLOGY

Role of Mitochondria in Nonalcoholic Fatty Liver Disease

(2014) Fatiha Nassir et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

International Harmonization of Nomenclature and Diagnostic Criteria (INHAND)

(2014) C. M. Keenan et al.   TOXICOLOGIC PATHOLOGY

Glucosylceramide and Lysophosphatidylcholines as Potential Blood Biomarkers for Drug-Induced Hepatic Phospholipidosis

(2014) Kosuke Saito et al.   TOXICOLOGICAL SCIENCES

Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator

(2013) Clifford R. Elcombe et al.   CRITICAL REVIEWS IN TOXICOLOGY

Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations

(2013) David E. Kleiner et al.   HEPATOLOGY

An updated review on drug-induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters

(2013) Kyunghee Yang et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Biliary Proliferative Lesions in the Sprague-Dawley Rat

(2013) James R. Hailey et al.   TOXICOLOGIC PATHOLOGY

Drug induced phospholipidosis: An acquired lysosomal storage disorder

(2012) James A. Shayman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Drug-Induced Cholestasis

(2012) Einar S. Bjornsson et al.   Clinics in Liver Disease

Phospholipidosis in Rats Treated with Amiodarone: Serum Biochemistry and Whole Genome Micro-Array Analysis Supporting the Lipid Traffic Jam Hypothesis and the Subsequent Rise of the Biomarker BMP

(2012) Natalie Mesens et al.   TOXICOLOGIC PATHOLOGY

Liver Hypertrophy

(2012) A. P. Hall et al.   TOXICOLOGIC PATHOLOGY

Nuclear receptors in liver disease

(2011) Martin Wagner et al.   HEPATOLOGY

Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

(2010) Karima Begriche et al.   JOURNAL OF HEPATOLOGY

Hepatic Enzyme Induction

(2010) Robert R. Maronpot et al.   TOXICOLOGIC PATHOLOGY

Diagnostic Performance of Traditional Hepatobiliary Biomarkers of Drug-Induced Liver Injury in the Rat

(2010) Daniela Ennulat et al.   TOXICOLOGICAL SCIENCES

Nuclear receptors: the controlling force in drug metabolism of the liver?

(2009) N. Plant et al.   XENOBIOTICA